Page 210 - Read Online
P. 210
conjugates are muscarinic cholinergic receptor antagonists. epidermal growth factor receptor in normal colonic mucosa and in
Pharmacology 2002;65:215-21. adenocarcinomas of the colon. Acta Physiol Hung 1997;85:121-8.
33. Cheng K, Xie G, Raufman JP. Matrix metalloproteinase-7- 42. Xie G, Cheng K, Shant J, Raufman JP. Acetylcholine-induced
catalyzed release of HB-EGF mediates deoxycholyltaurine-induced activation of M3 muscarinic receptors stimulates robust matrix
proliferation of a human colon cancer cell line. Biochem Pharmacol metalloproteinase gene expression in human colon cancer cells. Am
2007;73:1001-12. J Physiol Gastrointest Liver Physiol 2009;296:G755-63.
34. Hamilton JP, Xie G, Raufman JP, Hogan S, Griffin TL, Packard CA, 43. Raufman JP, Samimi R, Shah N, Khurana S, Shant J, Drachenberg
Chatfield DA, Hagey LR, Steinbach JH, Hofmann AF. Human cecal C, Xie G, Wess J, Cheng K. Genetic ablation of M3 muscarinic
bile acids: concentration and spectrum. Am J Physiol Gastrointest receptors attenuates murine colon epithelial cell proliferation and
Liver Physiol 2007;293:G256-63. neoplasia. Cancer Res 2008;68:3573-8.
35. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats 44. Raufman JP, Shant J, Xie G, Cheng K, Gao XM, Shiu B, Shah
T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C; N, Drachenberg CB, Heath J, Wess J, Khurana S. Muscarinic
Gastrointestinal Consortium Panel. Colorectal cancer screening and receptor subtype-3 gene ablation and scopolamine butylbromide
surveillance: clinical guidelines and rationale-update based on new treatment attenuate small intestinal neoplasia in Apcmin/+ mice.
evidence. Gastroenterology 2003;124:544-60. Carcinogenesis 2011;32:1396-402.
36. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin 45. Cheng K, Xie G, Khurana S, Heath J, Drachenberg CB, Timmons
JM. Increased tight junctional permeability is associated with the J, Shah N, Raufman JP. Divergent effects of muscarinic receptor
development of colon cancer. Carcinogenesis 1999;20:1425-31. subtype gene ablation on murine colon tumorigenesis reveals
37. Flynn C, Montrose DC, Swank DL, Nakanishi M, Ilsley JN, association of M3R and zinc finger protein 277 expression in colon
Rosenberg DW. Deoxycholic acid promotes the growth of colonic neoplasia. Mol Cancer 2014;13:77.
aberrant crypt foci. Mol Carcinog 2007;46:60-70. 46. Peng Z, Heath J, Drachenberg C, Raufman JP, Xie G. Cholinergic
38. Dawson PA, Haywood J, Craddock AL, Wilson M, Tietjen M, muscarinic receptor activation augments murine intestinal epithelial
Kluckman K, Maeda N, Parks JS. Targeted deletion of the ileal bile cell proliferation and tumorigenesis. BMC Cancer 2013;13:204.
acid transporter eliminates enterohepatic cycling of bile acids in 47. Belo A, Cheng K, Chahdi A, Shant J, Xie G, Khurana S, Raufman
mice. J Biol Chem 2003;278:33920-7. JP. Muscarinic receptor agonists stimulate human colon cancer cell
39. Raufman JP, Dawson PA, Rao A, Drachenberg CB, Heath J, Shang migration and invasion. Am J Physiol Gastrointest Liver Physiol
AC, Hu S, Zhan M, Polli JE, Cheng K. Slc10a2-null mice uncover 2011;300:G749-60.
colon cancer-promoting actions of endogenous fecal bile acids. 48. Raufman JP, Cheng K, Saxena N, Chahdi A, Belo A, Khurana S, Xie
Carcinogenesis 2015;36:1193-200. G. Muscarinic receptor agonists stimulate matrix metalloproteinase
40. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal 1-dependent invasion of human colon cancer cells. Biochem
growth factor-related peptides and their receptors in human Biophys Res Commun 2011;415:319-24.
malignancies. Crit Rev Oncol Hematol 1995;19:183-232. 49. Philip AK, Philip B. Colon targeted drug delivery systems: a review
41. Ozğul C, Karaöz E, Erdoğan D, Dursun A. Expression of on primary and novel approaches. Oman Med J 2010;25:79-87.
200
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ June 15, 2016 ¦